Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes.

J Neuroinflammation · 2015 · PMC4480507 · PMID 26077779

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

a strong trendp = 0.07so close (0.05 < p ≤ 0.1)

Results Increased IL-22 in active MS patients First, using ELISA, we found that there was a strong trend ( p = 0.07) for an increase of IL-22 protein in the serum of 63 MS patients as compared to 13 HC (Fig. 1a ).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.